Zobrazeno 1 - 10
of 23 541
pro vyhledávání: '"Influenza Vaccine"'
Autor:
Hua Shi, Ted M. Ross
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 409-418 (2024)
Introduction Vaccination is the most effective method to control the prevalence of seasonal influenza and the most widely used influenza vaccine is the inactivated influenza vaccine (IIV). Each season, the influenza vaccine must be updated to be most
Externí odkaz:
https://doaj.org/article/bb095c237d464d3780dbfed0d8daa178
Autor:
Huy Quang Quach, Iana H. Haralambieva, Krista M. Goergen, Diane E. Grill, Jun Chen, Inna G. Ovsyannikova, Gregory A. Poland, Richard B. Kennedy
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Older age (≥ 65 years) is associated with impaired responses to influenza vaccination, leading to the preferential recommendation of MF59-adjuvanted (MF59Flu) or high-dose (HDFlu) influenza vaccines for this age group in the United States.
Externí odkaz:
https://doaj.org/article/ce51629654d646adb5d67b575001e389
Autor:
Alzayani, Salman, Al Sedran, Mohammed, Aburowais, Safa, Hammad, Jumana, Almuaili, Noora, Alkawari, Shaikha, Bureshaid, Rayan, Almalki, Muhannad, Almarabheh, Amer, Ben Salah, Afif
Publikováno v:
Arab Gulf Journal of Scientific Research, 2023, Vol. 42, Issue 4, pp. 1577-1589.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/AGJSR-07-2023-0297
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 371-379 (2024)
Background Cell-based quadrivalent inactivated influenza vaccines (IIV4c) avoid egg-adaptive mutations found in egg-based production, improving vaccine effectiveness (VE). Studies demonstrate improved VE for IIV4c relative to egg-based quadrivalent i
Externí odkaz:
https://doaj.org/article/807c4c3d596840628d18191334031f74
Autor:
Myron J. Levin, Victoria Divino, Maarten J. Postma, Stephen I. Pelton, Zifan Zhou, Mitch DeKoven, Joaquin Mould-Quevedo
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 124-136 (2024)
Background Clinical evidence supports use of enhanced influenza vaccines in older adults. Few economic outcome studies have compared adjuvanted trivalent inactivated (aIIV3) and standard egg-derived quadrivalent inactivated influenza vaccines (IIV4e)
Externí odkaz:
https://doaj.org/article/e53c478a9aef4f41a22846665211f28e
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 82-87 (2024)
Background Cell-based quadrivalent influenza vaccines (QIVc) can increase effectiveness against seasonal influenza by avoiding mismatch from egg adaption of vaccine viruses. This study evaluates the population-level cost-effectiveness and impacts on
Externí odkaz:
https://doaj.org/article/75c97e014fc449a4872f595eb165ee12
Autor:
Francesco Lapi, Ettore Marconi, Elettra Fallani, Marco Salvatore, Maura Cambiaggi, Alessandro Rossi, Claudio Cricelli
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 8-15 (2024)
Background Delays in influenza vaccine delivery and administration can hinder vaccine coverage and protection. This study examines the differentials in distributing and administering adjuvanted trivalent (aTIV) and quadrivalent influenza vaccines (aQ
Externí odkaz:
https://doaj.org/article/752bd9d680fb4755a65519db9ffbb1b1
Autor:
Yiqun Zhang, Rong Liu, Yangyang Zhao, Zhiyan Wang, Chi Wang, Qiang Li, Dorothy Han, Craig S. Anderson, Xin Du, Jianzeng Dong
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Influenza vaccination confers broad benefits in the elderly and certain high-risk populations, but its effectiveness in patients with acute heart failure (HF) is uncertain. Rates of influenza vaccination are low in China due to po
Externí odkaz:
https://doaj.org/article/a979185c22dd4699b18e22339ee100a1
Publikováno v:
Shanghai yufang yixue, Vol 36, Iss 10, Pp 977-982 (2024)
ObjectiveTo understand the process and influencing factors affecting the utilization of influenza vaccination services and vaccination decision-making among the elderly in Shanghai, to explore the delivery of influenza vaccination services and the di
Externí odkaz:
https://doaj.org/article/c9216843835845ca9ced397bb023d7d2
Autor:
Mikhail Petrovich Kostinov, N. Yu. Nastaeva, N. F. Nikityuk, K. V. Mashilov, A. A. Khasanova, I. L. Solovyeva, N. P. Andreeva, Yu. A. Li, V. B. Polishchuk, Andrey V. Linok, M. N. Loktionova, A. M. Kostinova, I. A. Khrapunova
Publikováno v:
Инфекция и иммунитет, Vol 14, Iss 4, Pp 769-780 (2024)
Background.In the absence of a vaccine against SARS-CoV-2, seasonal influenza vaccination during the pandemic contributed to lowered COVID-19 susceptibility and severity. The study was aimed to assess the state of post-influenza vaccination immunity,
Externí odkaz:
https://doaj.org/article/be667b4dcb564685badc99100358606d